Introduction {#s0001}
============

Inflammatory diseases are mostly the result of uncontrolled inflammation leading to damage and destruction of healthy tissue (Minihane et al. [@CIT0035]). These processes involve major cells of the immune system, including macrophages, lymphocytes and especially polymorphonuclear neutrophils. Activated neutrophils release a variety of inflammatory mediators such as reactive oxygen species (ROS), proteolytic enzymes and cytokines (IL-1, IL-6, TNF, etc), which promote severe damage in the site of inflammation (Punchard et al. [@CIT0043]). Several inflammatory disorders including chronic obstructive pulmonary disease (COPD), emphesyma, rheumatoid arthritis, atherosclerosis and cancer are considered as major health care problem. The pathophysiology of these diseases is due to inflammatory/anti-inflammatory and oxidant/antioxidant imbalance. Polymorphonuclear neutrophils play a key role in host defenses against invading microorganisms (Hampton et al. [@CIT0023]), but excessive neutrophil activation participates in tissue damage associated with inflammatory disorders (Babior [@CIT0002], [@CIT0003]). In response to a variety of agents, neutrophils migrate to inflammatory sites, where they release proteases, bactericidal peptides, and large quantities of ROS in a process known as the respiratory burst (Babior [@CIT0002]). Oxygen reduction by neutrophil NADPH oxidase, a multicomponent enzyme system, yields superoxide anion (O^2−^) (El-Benna et al. [@CIT0013]), while myeloperoxidase (MPO) produces hypochloric acid from hydrogen peroxide (Klebanoff [@CIT0029]).

The matrix metalloproteinases especially MMP-2 and MMP-9 play an important role in these disorders notably in airway obstruction (Cataldo et al. [@CIT0007]). Some inflammatory diseases notably COPD and emphysema exhibited glucocorticoid resistance, till today no specific medicine to control such disorders is available. Thus, searching for new therapies and specific targets are the main goal of scientific research (Barnes and Adcock [@CIT0005]).

Since ancient times, plants have been used for therapeutic, cosmetic and nutritional purposes. In the last decades, researchers have investigated and characterized the proprieties and composition of several species herbs plants and demonstrated the rational of their use as a remedy of many health problems and disorders (Fabricant and Farnsworth [@CIT0016]).

*Syzygium aromaticum* (L.) Merr. & Perry (Myrtaceae) commonly called clove, is an aromatic medicinal plant. Dried flower buds have been used as a spice and flavour in food but it is also used in traditional East Asian medicines especially in dental care (Milind and Deepa [@CIT0034]; Cortés-Rojas et al. [@CIT0012]). In addition, cloves exhibit antibacterial (Nuñez and Aquino [@CIT0039]), antiviral (Hussein et al. [@CIT0024]) and antifungal activities (Hamini-Kadar et al. [@CIT0022]; Zore et al. [@CIT0050]). Various other pharmacological properties, such as antioxidant (Lee and Shibamoto [@CIT0031]), anti-inflammatory (Ahmad et al. [@CIT0001]) and antitumor effects, have also been reported (Banerjee et al. [@CIT0004]; Kumar et al. [@CIT0030]).

This work examines the effect of *S. aromaticum* aqueous extract (SAAE) on ROS production by human neutrophils, and its effect on lipopolysaccharide (LPS)-induced lung inflammation in mice.

Materials and methods {#s0002}
=====================

Chemicals and reagents {#s0003}
----------------------

Ficoll and Dextran T500 were purchased from GE Healthcare. Luminol, cytochrome c, *N*-formyl-methionyl-leucyl-phenylalanine (fMLF), phorbol myristate acetate (PMA) and *Escherichia coli* (O55:B6) LPS were from Sigma-Aldrich (Saint-Quentin Fallavier, France). Stock solutions of fMLF (10^−2^ mol/L) and PMA (1 mg/mL) were prepared in dimethyl sulfoxide (DMSO) and stored at −20 °C. The different solutions were diluted in phosphate-buffered saline (PBS) immediately before use.

Aqueous extract of clove flower buds {#s0004}
------------------------------------

Clove buds purchased from a local market of Gabes, were identified and voucher specimens are maintained in our laboratory. Aliquots of these buds were dried at 37 °C for 24 h, blended and the powder obtained was suspended in sterile saline solution (NaCl 0.9%) to have 0.1, 0.5, 1, 1.5, 2 µg/mL concentrations, then centrifuged at 2000 rpm for 3 min. From each batch, the supernatants of different preparations of SAAE were used for the experiments. The results that were obtained with different preparations from different batches are reproducible.

Ethics statement and isolation of human neutrophils {#s0005}
---------------------------------------------------

Neutrophils were isolated from the venous blood of healthy volunteers with their written informed consent in accordance with the Declaration of Helsinki. All experiments were approved by the INSERM Institutional Review Board and ethics committee. Data collection and analyses were performed anonymously. Neutrophils were isolated by Dextran sedimentation and density gradient centrifugation as previously described (El-Benna and Dang [@CIT0014]). Erythrocytes were removed by hypotonic lysis. Following isolation, the cells were resuspended in an appropriate medium, such as Hank's balanced salt solution (HBSS). The cells were counted and their viability was determined with the Trypan blue exclusion method.

Measurement of ROS production by chemiluminescence {#s0006}
--------------------------------------------------

Isolated cells were resuspended in HBSS at a concentration of 1 million per mL. Cell suspensions (5 × 10^5^) in 0.5 mL of HBSS containing 10 µM of luminol in the presence or absence of SAAE were preheated to 37 °C in the thermostated chamber of a luminometer (Berthold-Biolumat LB937) and allowed to stabilize. After a baseline reading, cells were stimulated with 10^−6^ M fMLF or 100 ng/mL PMA. Changes in chemiluminescence were measured over a 30-min period.

Measurement of superoxide production {#s0007}
------------------------------------

Isolated cells were resuspended in HBSS at a concentration of 1 million per mL. Cell suspensions in 1 ml of HBSS containing 1 mg/mL cytochrome c in the presence or absence of SAAE were preheated to 37 °C in the thermostated chamber of a spectrophotometer (Uvikon) and allowed to stabilize. After a baseline reading, cells were stimulated with 10^−6^ M fMLF or 100 ng/mL PMA. Changes in absorbance were measured at 550 nm over a 15-min period.

Detection of H~2~O~2~ {#s0008}
---------------------

In order to investigate whether SAAE reacts directly with H~2~O~2~, SAAE was incubated in PBS with H~2~O~2~ (80 µM) during 15 min in the presence of luminol (10 µM) and the reaction was initiated by adding horseradish peroxidase (HRPO) (5U). Changes in chemiluminescence were measured over a 15-min period.

Effect of SAAE on MPO degranulation {#s0009}
-----------------------------------

Neutrophils were pre-incubated with 5 µg/mL cytochalasin B for 5 min, then with SAAE for 15 min at 37 °C. Immediately tubes were centrifuged, and the cell-free supernatants were stored at −80 °C. Western blot analysis was used to quantify the degranulation of MPO in resting neutrophils and after stimulation with PMA at 100 ng/mL.

Preparation of azurophilic granules and measurement of MPO activity {#s0010}
-------------------------------------------------------------------

Neutrophils were lysed by nitrogen cavitation and the granule fraction was purified by Percol gradient centrifugation (Udby and Borregaard [@CIT0049]). The granules were sonicated in 0.2% cetyltrimethylammonium bromide (CTAB) and MPO activity was assessed by using the H~2~O~2~-dependent tetramethyl-benzedine (TMB) oxidation assay at 650 nm.

Measurement of cytochrome C oxidase and xanthine oxidase activities {#s0011}
-------------------------------------------------------------------

To study the effect of SAAE on cytochrome C oxidase and xanthine oxidase activity, the test of reduction of cytochrome C was used. Neutrophils were incubated in presence of SAAE, then stimulated with PMA or fMLF and the activity of the enzyme was detected at 550 nm. Xanthine oxidase was also preincubated with SAAE and xanthine as enzyme substrate. The activity was measured using a spectrophotometer at 550 nm.

Animals {#s0012}
-------

BALB/c mice aged 7 weeks and weighing 22--26 g were purchased from the animal facility of Faculty of sciences of Gabes. Animals were housed in standard wire-topped cages and the temperature-controlled units. Food and water were supplied *ad libitum*. The experiments were approved by our Institutional Committee on Animal Care and use and the experimental protocol complied with Tunisian legal requirements for animal's studies.

Induction of lung inflammation {#s0013}
------------------------------

LPS of *Escherichia coli* O55: B6 (Sigma) was used to induce lung inflammation. Animals were divided randomly into four groups with 8--10 mice in each group. (1) Control group, received saline (NaCl 0.9%), (2) SAAE group, received 200 mg/kg of clove extract by intraperitoneal route (IP) and saline by intratracheal route (IT). (3) LPS group, received saline by IP route and LPS (5 µg/mouse) by IT route. (4) SAAE + LPS group, received 200 mg/kg of clove extract by IP route and LPS (5 µg/mouse) by IT route.

According to group, the mice received a first IP injection \[Saline (group 1; and 3) or 200 mg/kg SAAE (group 2 and 4)\] on day 0 (D0). On D1, they received a second IP injection \[Saline (group 1; and 3) or 200 mg/kg SAAE (group 2 and 4)\]. Three hours after the second IP injection, the mice received a cocktail of anaesthetics \[75 mg/kg ketamin (Virbac Santé Animale, Carros, France) plus 1 mg/kg medetomidine (Pfizer, Paris, France)\], before IT instillation \[Saline (groups 1 and 3) or 5 µg LPS/mouse (groups 2 and 4)\]. The mice were aroused by an IP injection of 1 mg/kg atipamezol (Pfizer), a medetomidine antagonist, and were sacraficed 24 h later.

Bronchoalveolar lavage and lung sampling {#s0014}
----------------------------------------

The mice were anesthetized by an IP injection of 50 mg of pentothal (Sigma) and killed by exsanguination. The lungs were lavaged twice with 1 mL of physiological saline, removed rapidly and immediately frozen in liquid nitrogen and stored at −80 °C until use. The lavage fluid (2 mL) was immediately placed on ice. Free alveolar cells were recovered from the lavage fluid by centrifugation at 2500 rpm for 15 min at 4 °C. The total protein concentration in the supernatant and in the grinded lung was measured with the Quick-Start Bradford assay (Bio-Rad, Marnes-la-Coquette, France). The cell pellet was suspended in 150 µL of physiological saline and an aliquot was used to determine the total white cell count with a hemocytometer. For differential counts, the cell suspension was cytospun (Cytospin-2, Shandon Products Ltd, Levallois-Perret, France), fixed in methanol, and stained with Diff Quick solution (Medion Diagnostics, Plaisir, France). Three hundred cells were counted with an oil immersion lens (1000).

Zymography {#s0015}
----------

Samples of total proteins, lung grinded, were separated under non-reducing conditions on 12% polyacrylamide gels containing 1 mg/mL gelatin, as described previously (Ciccocioppo et al. [@CIT0008]). Gels were loaded with 4--10 µg of total proteins sample and run under Laemmli standard conditions. After electrophoresis, gels were washed twice in 100 mL of 2.5% Triton X-100 (30 min each) under constant mechanical agitation and incubated in activation buffer (50 mM Tris-HCl pH 7.5, 5 mM CaCl~2~, 1 µL Zn Cl~2~, 0.1 mM NaN~3~) at 37 °C for 72 h. Gels were stained with Coomassie blue. Visualization of MMP-2 and -9 activities was obtained by incubation of the gels in acetic acid 45% and methanol 10%, H~2~O and were quantified with Image J software.

Effect of SAAE on MPO activity *in vivo* {#s0016}
----------------------------------------

Clove buds were dried at 37 °C for 24 h, blended and the powder obtained was suspended in sterile saline solution (NaCl 0.9%), then centrifuged at 2000 rpm for 3 min. From each batch, the supernatants of different preparations of SAAE were used for the experiments. Animals were divided into two groups (four mice in each group). Control group, received saline (NaCl 0.9%), SAAE group, received 200 mg/kg of clove extract by IP injection. Twenty-four hours later, 0.5 mL blood was withdrawn from mice, red cells were lyzed by ammonium chloride, neutrophils were counted, sonicated in PBS +0.2% CTAB and MPO activity was measured as described above using the H~2~O~2~-dependent TMB oxidation assay at 655 nm.

Statistical analysis {#s0017}
--------------------

Data are reported as mean ± standard error. The Newman--Keuls multiple comparisons test was used, and *p* values \<0.05 were considered to denote significant differences.

Results {#s0018}
=======

SAAE inhibits luminol-amplified chemiluminescence in human neutrophils {#s0019}
----------------------------------------------------------------------

To investigate the effect of SAAE on neutrophils ROS production, human neutrophils were incubated with different SAAE concentrations and ROS were detected by luminol-amplified chemiluminescence. Results show that SAAE inhibited luminol-amplified chemiluminescence in resting neutrophils ([Figure 1(A)](#F0001){ref-type="fig"}), in neutrophils stimulated with fMLF ([Figure 1(B)](#F0001){ref-type="fig"}) and PMA ([Figure 1(C)](#F0001){ref-type="fig"}) with IC~50~ values of 0.5, 1.5 and 0.5 µg/mL respectively. In latter conditions, the effect of SAAE was concentration-dependent, with an inhibitory effect starting at a concentration as low as 0.5 µg/mL. As fMLF and PMA activate neutrophils through different transduction pathways, these results suggested that SAAE inhibits neutrophils ROS production by inhibiting a final common target such as the NADPH oxidase, MPO or that it scavenges ROS.

![Effect of SAAE on luminol-amplified chemiluminescence in human neutrophils. Human neutrophils (5 × 10^5^) were incubated in the presence or absence of different SAAE concentrations in resting conditions (A) and stimulated with fMLF (10^−6^ M) (B) or PMA (100 ng/mL) (C). Luminol-amplified chemiluminescence was measured for 30 min (mean ± SEM of three experiments, \**p* \< 0.05).](IPHB_A_1557697_F0001_B){#F0001}

SAAE has no effect on neutrophil superoxide production {#s0020}
------------------------------------------------------

To investigate the effect of SAAE on NADPH oxidase activity, we studied its effect on superoxide anion production by using the cytochrome c reduction assay, a specific technique to assess the activity of NADPH oxidase. As shown in [Figure 2](#F0002){ref-type="fig"}, SAAE had no effect on cytochrome c reduction by human neutrophils stimulated with fMLF ([Figure 2(A)](#F0002){ref-type="fig"}) or PMA ([Figure 2(B)](#F0002){ref-type="fig"}), suggesting that it does not affect NADPH oxidase activity nor scavenge superoxide anions.

![Effect of SAAE on superoxide anion production by neutrophils. Human neutrophils (10^6^) were incubated in the presence or absence of SAAE, and stimulated with fMLF (10^−6^ M) (A) or PMA (100 ng/mL) (B). Cytochrome c reduction was measured at 550 nm in a spectrophotometer for 15 min (mean ± SEM of three experiments, \**p* \< 0.05).](IPHB_A_1557697_F0002_B){#F0002}

SAAE does scavenge superoxide anion nor H~2~O~2~ {#s0021}
------------------------------------------------

Firstly, to investigate whether SAAE scavenges superoxide anions, xanthine/xanthine oxidase was used to produce superoxide anions, which were then detected by the cytochrome c reduction assay. Results show ([Figure 3(A)](#F0003){ref-type="fig"}) that SAAE had no effect on superoxide anions production by this system. Secondly, to investigate whether SAAE scavenges H~2~O~2~, SAAE was incubated in the presence of commercial H~2~O~2~ for 10 min, the reaction was started by the addition of HRP and luminol-amplified chemiluminescence was measured. Results show ([Figure 3(B)](#F0003){ref-type="fig"}) that SAAE had no effect on H~2~O~2~.

![Effect of SAAE on superoxide anions and H~2~O~2~*in vitro*. (A) Xanthine oxidase was incubated in the presence or absence of SAAE, xanthine was added and superoxide anions were detected by the cytochrome c reduction assay. (B) H~2~O~2~ was incubated in the presence or absence of SAAE and detected using HRP-amplified chemiluminescence (mean ± SEM of three experiments, \**p* \< 0.05).](IPHB_A_1557697_F0003_B){#F0003}

Effect of SAAE on MPO activity from azurophilic granules {#s0022}
--------------------------------------------------------

As luminol-amplified chemiluminescence is dependent on MPO activity, the effect of SAAE on MPO activity was tested. Azurophilic granules extracts were incubated with different concentrations of SAAE, and MPO activity was measured using H~2~O~2~-TMB oxidation assay. As shown in [Figure 4](#F0004){ref-type="fig"}, SAAE inhibited MPO activity in a concentration-dependent manner with IC~50~ of 0.5 µg/mL. These results suggest that SAAE inhibits luminol-amplified chemiluminescence in neutrophils by inhibiting MPO activity.

![Effect of SAAE on MPO activity. MPO was incubated with or without SAAE and its activity was measured in terms of tetra-methylbenzidine oxidation at 655 nm (mean ± SEM of three experiments, \**p* \< 0.05).](IPHB_A_1557697_F0004_B){#F0004}

Effect of SAAE on MPO degranulation {#s0023}
-----------------------------------

MPO is an important indicator of polymorphonuclear leukocytes activation. It is released from azurophil granules of activated neutrophils. We evaluated the effect of SAAE on MPO degranulation. Results show that SAAE had no effect on MPO degranulation in resting neutrophils ([Figure 5(A)](#F0005){ref-type="fig"}) and also in neutrophils stimulated with PMA ([Figure 5(B)](#F0005){ref-type="fig"}).

![Effect of SAAE on MPO degranulation. Isolated human neutrophils (5 × 10^5^) were incubated in the presence or absence of different SAAE concentrations in resting conditions (A), and stimulated with PMA (100 ng/mL) (B). MPO dégranulation was detected using western blot, MPO bands were quantified and expressed as % of control (mean ± SEM of three experiments, \**p* \< 0.05).](IPHB_A_1557697_F0005_B){#F0005}

Effect of SAAE on BALF protein content and cellularity in LPS-treated mice {#s0024}
--------------------------------------------------------------------------

IT administration of 5 µg of LPS to mice induced a significant increase in bronchoalveolar lavage fluid (BALF) protein content after 24 h, compared with animals treated with either the vehicle or SAAE alone ([Figure 6](#F0006){ref-type="fig"}). The BALF protein content after IT LPS challenge was significantly lower when animals were pretreated with 200 mg/kg SAAE ([Figure 6](#F0006){ref-type="fig"}). IT LPS administration also induced a significant increase in both the BALF total cell count (*p* \< 0.05 vs. vehicle or SAAE alone; [Figure 7(A)](#F0007){ref-type="fig"}) and the BALF neutrophil count after 24 h (*p* \< 0.05 vs. vehicle or SAAE alone; [Figure 7(B,C)](#F0007){ref-type="fig"}). Neither the vehicle nor SAAE at 200 mg/kg modified the BALF cell count. However, intra-peritoneal SAAE injection at 200 mg/kg significantly reduced the BALF total cell count after IT administration of LPS (*p* \< 0.05 vs. LPS alone). Simultaneous administration of LPS and SAAE significantly reduced neutrophils recruitment compared to LPS alone (*p* \< 0.05 vs. LPS; [Figure 7(B,C)](#F0007){ref-type="fig"}).

![Effect of SAAE on the protein concentration of mouse bronchoalveolar lavage fluid (BALF). Protein was measured in BALF 24 h after intra-tracheal instillation of lipopolysaccharide (LPS 5 µg/mouse) or in controls. LPS induced a massive increase in the protein content, which was significantly attenuated by SAAE (200 mg/kg) (*n* = 8, mean ± SEM, \**p* \< 0.05).](IPHB_A_1557697_F0006_B){#F0006}

![Effect of SAAE on BALF cell content. BALB/c mice were treated with vehicle (NaCl 0.9%), SAAE (200 mg/kg), LPS (5 µg/mouse) or SAAE (200 mg/kg) plus LPS (5 µg/mouse), and cells were counted in BALF. (A), Total cell counts; (B) and (C), Neutrophils counts (*n* = 8, mean ± SEM, \**p* \< 0.05).](IPHB_A_1557697_F0007_C){#F0007}

SAAE inhibits MMP-2 and MMP-9 activity in lung tissues {#s0025}
------------------------------------------------------

To investigate the effect of SAAE on matrix metalloproteases (MMP-2, MMP-9) activity, the technique of zymography was used. Results ([Figure 8](#F0008){ref-type="fig"}) showed that the activity of these enzymes increased following LPS IT instillation compared to animals treated either with saline or SAAE alone. However, this increase was suppressed when mice were pretreated with 200 mg/kg of SAAE. A decrease of both MMP-2 ([Figure 8(A)](#F0008){ref-type="fig"}) and MMP-9 ([Figure 8(B)](#F0008){ref-type="fig"}) activities, 15% and 18%, respectively, were observed. However, neither the saline or SAAE at 200 mg/kg modified the MMPs activity in lung homogenate.

![Effect of SAAE on MMP-2 (A) and MMP-9 (B) activities in lung homogenates. BALB/c mice were treated with vehicle (NaCl 0.9%), SAAE (200 mg/kg), LPS (5 µg/mouse) or SAAE (200 mg/kg) plus LPS (5 µg/mouse), lungs were homogenate and centrifuged. MMPs activity was detected in supernatants using Gelatin zymography technique. Results were expressed as a percentage relative to control (*n* = 8, mean ± SEM, \**p* \< 0.05).](IPHB_A_1557697_F0008_B){#F0008}

SAAE inhibits MPO activity *in vivo* {#s0026}
------------------------------------

Treatment of animals with 200 mg/kg of SAAE decreased significantly the activity of MPO, *in vivo*, as compared to control group (*p* \< 0.05). [Figure 9](#F0009){ref-type="fig"} showed that the extract inhibited about 25% of the enzyme activity.

![Effect of SAAE on MPO activity *in vivo*. Mice were treated with vehicle (NaCl 0.9%) or SAAE (200 mg/kg), after 24 h, MPO activity was measured in circulating neutrophils using tetra-methylbenzidine oxidation at 655 nm (mean ± SEM of *n* = 4, \**p* \< 0.05).](IPHB_A_1557697_F0009_B){#F0009}

Discussion {#s0027}
==========

In this study, we show that SAAE inhibits ROS-dependent luminol-amplified chemiluminescence in resting, fMLF and PMA stimulated neutrophils. However, SAAE had no direct effect on superoxide anion or H~2~O~2~ levels but markedly inhibited MPO activity. In addition, SAAE attenuated LPS-induced lung inflammation in mice and reduces the activity of MMP-2 and -9.

SAAE inhibited luminol-amplified chemiluminescence in human neutrophils stimulated with the chemotactic peptide fMLF or the protein kinase C activator PMA. As fMLF and PMA induce NADPH oxidase activation through different transduction pathways, these results suggest that SAAE does not affect a specific transduction pathway but directly inhibits a final common biochemical target such as NADPH oxidase or MPO, or that it scavenges ROS. Our results showed that SAAE had no effect on cytochrome c reduction, a specific technique for superoxide anion detection, suggesting that SAAE does not affect NADPH oxidase activity or scavenge superoxide anions.

Luminol-amplified chemiluminescence can be used to assay both released and retained neutrophils ROS, as luminol is a membrane-permeable molecule. Luminol-amplified chemiluminescence is dependent on H~2~O~2~ and on peroxidases such as cytosolic peroxidases and MPO (Dahlgren and Karlsson [@CIT0041]). To determine whether SAAE reacts with H~2~O~2~, we used a more specific technique to detect H~2~O~2~ in intact cells, based on DCFH oxidation. SAAE did not affect the amount of H~2~O~2~, suggesting that SAAE does not react with intracellular H~2~O~2~. However, SAAE inhibited MPO activity *in vitro* and exerted a potent anti-inflammatory effect in the lungs of mice exposed to LPS, reducing the BALF protein content, total cell number and neutrophil count.

BALF from mice exposed to LPS contained a large amount of protein, reflecting high-permeability pulmonary edema. The BALF protein concentration was significantly reduced by SAAE treatment, suggesting that SAAE reduces lung vascular permeability and edema, and might, therefore, protect the integrity of the alveolocapillary membrane. The reduction in neutrophils infiltration could explain these beneficial effects, as neutrophils are considered as primary cellular effector of alveolocapillary damage in COPD and asthma (Pesci et al. [@CIT0042], Fabbri et al. [@CIT0015]).

Expression and activity of various MMPs have been reported in pathological conditions, such as COPD, emphysema, allergic lung inflammation and arthritis, but they are also implicated in cancer. They regulate recruitment, influx and transmigration of inflammatory cells from vasculature to the site of inflammation in tissue (Fanjul-Fernández et al. [@CIT0017]). MMPs regulate the availability and activity of inflammatory mediators, such as cytokines and chemokines and they are implicated in creating chemokine gradients in tissue to recruit inflammatory cells to the site of injury or inflammation and can also regulate survival of inflammatory cells (Butler and Overall [@CIT0006]). In this work, we found that SAAE exhibited an inhibitory effect against MMP-2 and -9, two metalloproteases known with their involvement in chronic lung inflammatory diseases.

Using allergic lung inflammation model, Corry et al. ([@CIT0010]), reported a reduction in the influx of inflammatory cells to the alveolar space in MMP-9-null mice. In the same model, the role of MMP-2 in leukocyte migration to the inflammation site was also demonstrated (Corry et al. [@CIT0009], [@CIT0010]). In fact, MMP-9 exhibited more potent effect on inflammation than MMP-2 since various chemokines are affected by lack of MMP-9 resulting in disturbed influx of both neutrophils and eosinophils (Corry et al. [@CIT0010]). MMP-9 plays an important role in reepithelization in tissue repair in the lung. Activated neutrophils released MMP-9 which cleaves and inactivates the serine protease inhibitor α1-antitrypsin known for its potent inhibition of neutrophil elastase. Thus, MMP-9 can this way indirectly promote the activity of neutrophil elastase also implicated in lung injury.

A previous *in vitro* study (Nam and Kim [@CIT0026]) reported that eugenol the most representative compound of clove exhibited antioxidant activity and inhibits MMP-9 related to metastasis in human fibrosarcoma cells. This team showed that eugenol at 50 µM exhibited about 20% of inhibitory effect on MMP-9 activation in HT1080 cells compared to with PMA treatment group. Our results are consistent with these finding. In fact, the activities of MMP-2 and MMP-9 in the lungs of animals pretreated with SAAE and challenged with LPS were significantly decreased to 15% and 18%, respectively. However, neither the saline nor SAAE at 200 mg/kg modified the MMPs activity.

MPO, an enzyme generating chlorinated oxidants, is not only implicated in antimicrobial defence but also in activating MMP, through the formation of ROS, playing an important role in the activation and induction of inflammation (Robert et al. [@CIT0044]). MPO activity likely reflects an inflammatory infiltrate consisting partly of neutrophils, and neutrophil-derived elastase but also activating some chemokine (Meijer et al. [@CIT0033]). The activation of MMP-9 potentiates pro-inflammatory interleukin-8 (Van den Steen et al. [@CIT0048]) and processes IL-1β into an active form (Schonbeck et al. [@CIT0045]). MPO stimulates murine peritoneal macrophages to produce ROS (Lincoln et al. [@CIT0032]; Gelderman et al. 1998). Secreted ROS is known to enhance the secretion of alveolar macrophage-derived TNFα and IL-8, potent proinflammatory cytokines involved in recruitment of PMN to sites of inflammation (Nelson and Summer [@CIT0037]; Gibson et al. [@CIT0019]). Our results show that SAAE inhibited MPO activity *in vitro* and *in vivo.* Also, it reduced MMP-2 and -9 activities in lung homogenate, an effect possibly explaining the anti-inflammatory action observed *in vivo*.

Fruits, vegetables and spices, such as clove, oregano, mint, thyme and cinnamon, are important sources of antioxidants, including ascorbic acid, carotenoids, flavonoids and hydrolyzable tannins. Epidemiological studies indicate that populations that consume products rich in specific polyphenols have a lower incidence of inflammatory disorders such as cardiovascular and cerebrovascular disease, as well as certain cancers (Huxley and Neil [@CIT0025]; Temple and Gladwin [@CIT0047]). Clove represents one of the major vegetal sources of phenolic compounds as flavonoids, hidroxibenzoic acids, hidroxicinamic acids and hidroxiphenylpropens. With regard to the phenolic acids, eugenol is the main bioactive compound of clove is found in higher concentration (Shan et al. [@CIT0046]). Roughly, 89% of the clove essential oil is eugenol and 5--15% is eugenol acetate and β-cariofileno (Jirovetz et al. [@CIT0027]). Other phenolic acids found in clove are the caffeic, ferulic, elagic and salicylic acids but also some flavonoids such as kaempferol, quercetin and its derivates.

Thus, the beneficial effects of cloves are attributed to phenolic compounds including phenolic acids (gallic acid), flavonolglucosides, phenolic volatile oils (eugenol, acetyl eugenol) and tannins (Cortés-Rojas et al. [@CIT0012]). These compounds scavenge free radicals and inhibit lipid oxidation *in vitro* (Gil et al. [@CIT0020]; Noda et al. [@CIT0038]). A comparative study of antioxidant properties and total phenolic content of 30 plant extracts of industrial interest using DPPH, ABTS, FRAP, SOD and ORAC assays showed that clove and plants as pine, cinnamon and mate proved its enormous potential as food preservative among the 30 plants analyzed (Dudonne et al. [@CIT0011]). Further studies are needed to identify the precise compounds responsible for the MPO and MMP-2 and -9 activities inhibition observed in this work.

Conclusions {#s0028}
===========

In conclusion, SAAE inhibited neutrophil luminol-amplified chemiluminescence *in vitro*, by inhibiting MPO. SAAE attenuated inflammation induced by IT endotoxin instillation in mice, leading to a decrease in the BALF protein concentration, total cellularity and neutrophils content but it also inhibits MMP-2 and -9, two metalloproteinases involved in many inflammatory and destructive tissue diseases.
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